Martingale Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-38,625
| Closed | -$973K | – | 795 |
|
|
2024
Q1 | $973K | Sell |
38,625
-30,465
| -44% | -$767K | 0.02% | 478 |
|
|
2023
Q4 | $2.24M | Sell |
69,090
-160
| -0.2% | -$5.2K | 0.05% | 263 |
|
|
2023
Q3 | $1.89M | Sell |
69,250
-9,512
| -12% | -$259K | 0.04% | 280 |
|
|
2023
Q2 | $1.75M | Buy |
78,762
+4,013
| +5% | +$89.3K | 0.03% | 305 |
|
|
2023
Q1 | $1.62M | Buy |
74,749
+1,088
| +1% | +$23.6K | 0.03% | 319 |
|
|
2022
Q4 | $1.5M | Buy |
73,661
+2,603
| +4% | +$52.9K | 0.03% | 339 |
|
|
2022
Q3 | $1.82M | Buy |
71,058
+306
| +0.4% | +$7.85K | 0.04% | 270 |
|
|
2022
Q2 | $1.68M | Buy |
70,752
+57,028
| +416% | +$1.36M | 0.03% | 323 |
|
|
2022
Q1 | $310K | Sell |
13,724
-53,242
| -80% | -$1.2M | ﹤0.01% | 721 |
|
|
2021
Q4 | $1.33M | Buy |
66,966
+2,312
| +4% | +$45.8K | 0.02% | 413 |
|
|
2021
Q3 | $1.27M | Buy |
+64,654
| New | +$1.27M | 0.02% | 452 |
|